FDA's NDA And BLA Approvals: Abilify Mycite, Mepsevii, Hemlibra
Original new drugs and biologics recently approved by US FDA.
You may also be interested in...
Public Company Edition: Denali launched this year's largest biopharma IPO. Also, Valeant sold notes to retire older debt, while bluebird, Blueprint and others capitalized on data presented at ASH.
Otsuka plans a slow, measured launch of Abilify MyCite, developed with Proteus Health. The product includes an ingested sensor that sends a signal to a wearable patch and an app that tracks ingestion, activity and mood to potentially improve management of psychiatric care.
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.